{"id":37931,"date":"2026-07-07T21:09:37","date_gmt":"2026-07-07T21:09:37","guid":{"rendered":"https:\/\/selmiswiss.com\/?post_type=product&#038;p=37931"},"modified":"2026-07-07T21:38:48","modified_gmt":"2026-07-07T21:38:48","slug":"tesamorelin","status":"publish","type":"product","link":"https:\/\/selmiswiss.com\/en\/product\/tesamorelin\/","title":{"rendered":"Tesamorelin"},"content":{"rendered":"<div class=\"selmi-peptide-sheet\">\n<div class=\"selmi-peptide-header\">\n<div class=\"selmi-peptide-title\">Tesamorelin<\/div>\n<div class=\"selmi-peptide-category\">Growth hormone \/ Visceral fat<\/div>\n<\/p><\/div>\n<div class=\"selmi-peptide-grid selmi-peptide-grid-top\">\n<section class=\"selmi-peptide-main\">\n<div class=\"selmi-peptide-section\">\n<h3>MECHANISM OF ACTION<\/h3>\n<p>A stabilized synthetic analog of GHRH, with a trans-3-hexenoic acid modification that improves metabolic stability. It binds to the GHRH receptor in the anterior pituitary with high affinity, stimulating the pulsatile release of GH. Its pulsatile profile preserves natural feedback. The subsequent increase in IGF-1 mediates the reduction of visceral fat through enhanced lipolysis.   <\/p>\n<\/p><\/div>\n<div class=\"selmi-peptide-section\">\n<h3>KEY BENEFITS<\/h3>\n<ul>\n<li>FDA Approves Treatment to Reduce Visceral Fat Associated with HIV.<\/li>\n<li>Significant reduction in visceral fat in clinical trials.<\/li>\n<li>Improvement in lipid profile and metabolic health.<\/li>\n<li>Preservation of GH&#8217;s natural pulsatile physiology.<\/li>\n<li>Cognitive Benefits: IGF-1 Modulation in Research on Mild Cognitive Impairment.<\/li>\n<\/ul><\/div>\n<\/section>\n<aside class=\"selmi-peptide-dosing\">\n<h3>THE RESULTS DESCRIBED WERE OBTAINED BY FOLLOWING THE DOSAGE AND PROTOCOL SET FORTH BELOW<\/h3>\n<h4>1\u20132 mg\/day subcutaneous<\/h4>\n<p><strong>Vial size:<\/strong><br \/>2 mg<\/p>\n<p><strong>Frequency:<\/strong><br \/>Once a day<\/p>\n<p><strong>IU \/ Serving Size:<\/strong><br \/>100 IU<\/p>\n<p><strong>Reconstitution:<\/strong><br \/>Reconstitute with 2 mL of bacteriostatic water. 100 IU = 1 mg. <\/p>\n<p><strong>Cycle:<\/strong><br \/>6\u201312 months according to the FDA label. Off-label use: 12\u201324-week cycles. <\/p>\n<\/aside><\/div>\n<div class=\"selmi-peptide-grid selmi-peptide-grid-info\">\n<section class=\"selmi-peptide-box\">\n<h3>SIDE EFFECTS AND SAFETY<\/h3>\n<p>The most common side effects are injection-site reactions, fluid retention, joint pain, and glucose intolerance. Monitor HbA1c. Monitoring of IGF-1 is recommended.  <\/p>\n<\/section>\n<section class=\"selmi-peptide-box selmi-peptide-box-alt\">\n<h3>RESEARCH AND CLINICAL NOTES<\/h3>\n<p>AWARE Trial: Tesamorelin reduced visceral adipose tissue by 15\u201320% at 26 weeks compared with placebo in HIV-associated lipodystrophy. Approved by the FDA as Egrifta. Off-label use for visceral obesity not associated with HIV is expanding.  <\/p>\n<\/section><\/div>\n<section class=\"selmi-peptide-profile\">\n<h3>TARGET PROFILE:<\/h3>\n<p><em>HIV medicine, metabolic medicine, visceral fat management programs, and anti-aging protocols.<\/em><\/p>\n<\/section>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<div class=\"selmi-div-disclaimer\"><span class=\"selmi-disclaimer-text\">FOR PRECLINICAL RESEARCH USE ONLY \u2014 NOT APPROVED FOR HUMAN USE.<\/span><\/div>\n<ul>\n<li>FDA Approves Treatment to Reduce Visceral Fat Associated with HIV.<\/li>\n<li>Significant reduction in visceral fat in clinical trials.<\/li>\n<li>Improvement in lipid profile and metabolic health.<\/li>\n<li>Preservation of GH&#8217;s natural pulsatile physiology.<\/li>\n<li>Cognitive Benefits: IGF-1 Modulation in Research on Mild Cognitive Impairment.<\/li>\n<\/ul>\n","protected":false},"featured_media":37941,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[1115],"product_tag":[1101],"class_list":["post-37931","product","type-product","status-publish","has-post-thumbnail","product_cat-obesity-metabolism-peptides","product_tag-peptides","first","instock","taxable","shipping-taxable","purchasable","product-type-simple"],"acf":[],"_links":{"self":[{"href":"https:\/\/selmiswiss.com\/en\/wp-json\/wp\/v2\/product\/37931","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/selmiswiss.com\/en\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/selmiswiss.com\/en\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/selmiswiss.com\/en\/wp-json\/wp\/v2\/comments?post=37931"}],"version-history":[{"count":3,"href":"https:\/\/selmiswiss.com\/en\/wp-json\/wp\/v2\/product\/37931\/revisions"}],"predecessor-version":[{"id":37959,"href":"https:\/\/selmiswiss.com\/en\/wp-json\/wp\/v2\/product\/37931\/revisions\/37959"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/selmiswiss.com\/en\/wp-json\/wp\/v2\/media\/37941"}],"wp:attachment":[{"href":"https:\/\/selmiswiss.com\/en\/wp-json\/wp\/v2\/media?parent=37931"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/selmiswiss.com\/en\/wp-json\/wp\/v2\/product_brand?post=37931"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/selmiswiss.com\/en\/wp-json\/wp\/v2\/product_cat?post=37931"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/selmiswiss.com\/en\/wp-json\/wp\/v2\/product_tag?post=37931"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}